首页 › 胶质母细胞瘤 › 北卡罗来纳州 › Winston-Salem
Winston-Salem NC 胶质母细胞瘤临床试验
8项针对 胶质母细胞瘤的研究正在 Winston-Salem及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
招募中1/2 期
- Wake Forest University Health Sciences, Winston-Salem
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
招募中2/3 期
- Comprehensive Cancer Center of Wake Forest*, Winston-Salem
Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
招募中1 期
- Wake Forest University, Winston-Salem
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
招募中1 期
- Wake Forest University Health Sciences, Winston-Salem
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
招募中3 期
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
招募中2 期
- Wake Forest University Health Sciences, Winston-Salem
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
招募中2 期
- Wake Forest University Health Sciences, Winston-Salem
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Winston-Salem
其他城市的 胶质母细胞瘤试验
- New York City, NY30 项研究
- Boston, MA28 项研究
- Houston, TX26 项研究
- Los Angeles, CA24 项研究
- Durham, NC20 项研究
- San Francisco, CA17 项研究
- Chicago, IL15 项研究
- Washington, DC15 项研究
- Columbus, OH14 项研究
- Miami, FL14 项研究
- Rochester, MN13 项研究
- Jacksonville, FL13 项研究
Winston-Salem的其他研究
- 癌症（所有类型）19 项研究
- 急性髓系白血病18 项研究
- 多发性骨髓瘤14 项研究
- 乳腺癌14 项研究
- 心血管疾病14 项研究
- 非小细胞肺癌12 项研究
- 慢性阻塞性肺病10 项研究
- 卵巢癌10 项研究
- 2型糖尿病9 项研究
- 骨髓增生异常综合征9 项研究
- 慢性淋巴细胞白血病8 项研究
- 肺癌8 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。